ClinicalTrials.Veeva

Menu

Dynamic Alterations of Th2/Th1 With New Onset of Community-acquired Severe Sepsis Patients

J

Jianfeng Xie

Status

Completed

Conditions

Sepsis

Study type

Observational

Funder types

Other

Identifiers

NCT02883218
2014ZDSYLL087.0

Details and patient eligibility

About

To evaluate the dynamic alterations of Th2/Th1 for the prediction of clinical immunity and how it was related to 28 day-prognosis and ICU-acquired infections among critically ill patients of community-acquired severe sepsis with new onset.

Enrollment

85 patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

For community-acquired severe sepsis group:

Inclusion Criteria:

  • at least 18 years of age and no more than 90 years of age
  • sepsis was defined according to consensus criteria
  • diagnosis of sepsis and complicatied with organ dysfunction no longer than 48 h
  • provided written informed consent.

Exclusion Criteria:

  • diagnosis of hematological,immunological disease or cancer
  • treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization

For non-severe sepsis ICU control group:

Inclusion Criteria:

  • at least 18 years of age and no more than 90 years of age
  • without diagnosis of sepsis and admitted to ICU
  • provided written informed consent.

Exclusion Criteria:

  • diagnosis of hematological,immunological disease or cancer
  • treatment with chemotherapy agents or corticosteroids within 6 months prior to or during the hospitalization

For healthy control group:

Inclusion Criteria:

  • at least 18 years of age and no more than 90 years of age
  • provided written informed consent.

Exclusion Criteria:

  • diagnosis of hematological,immunological disease or cancer
  • treatment with chemotherapy agents or corticosteroids within 6 months prior to enrollment

Trial design

85 participants in 3 patient groups

Comunity-acquired severe sepsis patients
Description:
Patients with new-onset community-acquired severe sepsis within 24h without confounding factors in immune status
Non-severe sepsis patients
Description:
Patients between 18 and 90 years of age and be admitted to the ICU without a diagnosis of severe sepsis.
Healthy controls
Description:
Heathy vonlunteers between 18 and 90 years of age.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems